The recent stock activity involving director Mark Garrett at Snowflake Inc. (NYSE:SNOW) presents a mixed picture of personal investment decisions against the backdrop of significant corporate performance metrics.
On May 29, 2026, Mr. Garrett reported selling 100,000 shares of common stock, realizing a total value of $25,000,200. These sales were executed at a weighted-average price of $250.002 per share, with individual transaction prices observed ranging between $250.000 and $250.170. Counterbalancing this sale, the same day saw Mr. Garrett acquiring 100,000 shares of common stock for a cost of $3.74 per share, amounting to $374,000.
The acquisition portion was facilitated by the exercise of a fully vested stock option, allowing Mr. Garrett to purchase the 100,000 shares at an exercise price of $3.74 per share. It is noted that this specific option agreement has an expiration date set for April 14, 2028.
Following these transactions, Mr. Garrett's direct holdings in Snowflake common stock total 8,801 shares. This figure includes shares anticipated to be issued through the vesting of restricted stock units (RSUs). Furthermore, his indirect stake is substantial, comprising 121,010 shares held across various trusts for which his children are designated beneficiaries.
The timing of the reported sale has drawn attention due to the subsequent movement in Snowflake's share price. Since the transactions, SNOW shares have increased significantly, reaching $279.96 and posting a 62.7% return over the past week. The stock is currently trading near its 52-week high of $284.99.
In parallel to these personal movements, Snowflake Inc. recently disclosed robust financial results for the first quarter of fiscal 2027. These earnings demonstrated substantial operational strength: product revenue reached $1.334 billion, marking a considerable increase of 33.9% year-over-year and exceeding FactSet consensus expectations by 5.3%. Moreover, the company's operating income surpassed analyst estimates by 35.2%, an achievement noted as the strongest sequential dollar growth in Snowflake’s history.
This strong performance has prompted several financial institutions to reassess their outlook on the stock. Monness, Crespi, and Hardt increased their price target to $320. Benchmark also issued a new target of $270, while maintaining a Buy rating. HSBC upgraded its assessment to Buy from Hold and raised its price target to $289, specifically highlighting the adoption of Snowflake’s AI product, CoCo. Cantor Fitzgerald adjusted its price target upward to $282, citing the first-quarter results as evidence of a positive inflection point. Additionally, Freedom Broker revised its price target to $300, pointing to the strong earnings and accelerated monetization of its AI products.
Despite the company's growth momentum and analyst upgrades, some valuation concerns remain visible. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value, placing it among companies identified on the most overvalued list.
Risks
- Valuation risk is explicitly pointed out by InvestingPro analysis, which suggests that the stock currently appears overvalued relative to its Fair Value, classifying it among companies on the most overvalued list.
- The personal transactions of a director, including a significant sale ($25M) and acquisition ($374K), introduce complexity. While the timing was 'fortuitous' given the subsequent share price surge, this level of insider activity can sometimes signal differing internal views or liquidity needs that are not fully transparent.
- The dependency on continued AI product monetization and market acceptance remains a factor, as analysts cite accelerated AI product monetization as a key positive driver. Failure to sustain this growth rate could impact future valuation.
More from Insider Trading